Supplemental NJCCR Bridge Grant Guidelines for RFA 2027
Forecasted
The Supplemental NJCCR Bridge Grant supports New Jersey faculty in maintaining cancer research projects during short-term gaps in federal funding.
Browse similar grants
Funder: New Jersey Commission on Cancer Research
Due Dates (Anticipated): December 2026 (Mandatory Letter of Intent) | March 2027 (Application Due in SAGE)
Funding Amounts: Up to $200,000 total for a two-year project; indirect costs capped at 15% (inclusive); no PI salary allowed.
Summary: Supports NJ faculty with recently funded major federal cancer research grants to maintain research continuity during short-term lapses in federal funding.
Key Information: Mandatory technical assistance session and Letter of Intent required; only one application per PI per cycle.
Description
This opportunity provides bridge funding for cancer researchers in New Jersey who have recently managed major federal peer-reviewed grants and are facing a temporary lapse in federal research support. The goal is to help maintain research momentum and competitiveness for future federal funding, ensuring critical cancer research projects can continue without interruption. Funding is intended for research focused on cancer prevention, diagnosis, treatment, or survivorship, and is available exclusively to full-time faculty at qualifying New Jersey research institutions.
